Stay updated with breaking news from Daniel Janney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price target boosted by HC Wainwright from $119.00 to $139.00 in a report released on Monday, The Fly reports. HC Wainwright also issued estimates for Krystal Biotech’s Q3 2023 earnings at ($1.02) EPS, Q4 2023 earnings at ($0.93) EPS, FY2023 earnings at ($4.90) EPS, FY2024 earnings at […]
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price target increased by Chardan Capital from $133.00 to $148.00 in a research report sent to investors on Monday morning, The Fly reports. Chardan Capital also issued estimates for Krystal Biotech’s FY2023 earnings at ($5.46) EPS and FY2024 earnings at $3.03 EPS. A number of other research […]
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price target raised by equities research analysts at Stifel Nicolaus from $102.00 to $145.00 in a report issued on Wednesday, The Fly reports. Stifel Nicolaus’ price objective suggests a potential upside of 23.52% from the stock’s current price. Other equities analysts have also recently issued reports about […]
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its target price hoisted by Guggenheim from $101.00 to $130.00 in a research report released on Monday morning, The Fly reports. Other equities analysts also recently issued reports about the stock. Chardan Capital boosted their price target on shares of Krystal Biotech from $133.00 to $148.00 in a […]
Citigroup Inc. cut its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) by 42.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 28,760 shares of the company’s stock after selling 21,063 shares during the quarter. Citigroup Inc.’s holdings in Krystal Biotech were worth $2,278,000 at the end of the […]